
Neurology
Falling blood pressure and BMI in T2D may signal early dementia
13 days ago · 3 min read
Browse all clinical evidence, news, and expert commentary


The EVOKE trials are in, and the answer is no. Novo Nordisk has terminated the programme and discontinued the planned one-year extension of both trials.